share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

Recursion Pharmaceuticals | 4：持股變動聲明-高管 Marriott Tina
美股SEC公告 ·  08/19 19:13

Moomoo AI 已提取核心訊息

Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 14,319 shares of the company's Class A Common Stock on August 15, 2024. The shares were sold at a price of $6.69 per share, resulting in a total transaction value of $95,794.11. Following the transaction, Marriott's direct holdings in Recursion Pharmaceuticals amount to 521,138 shares. The sale was conducted under a transaction code indicating the payment of exercise price or tax liability by delivering or withholding securities.
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 14,319 shares of the company's Class A Common Stock on August 15, 2024. The shares were sold at a price of $6.69 per share, resulting in a total transaction value of $95,794.11. Following the transaction, Marriott's direct holdings in Recursion Pharmaceuticals amount to 521,138 shares. The sale was conducted under a transaction code indicating the payment of exercise price or tax liability by delivering or withholding securities.
2024年8月15日，Recursion Pharmaceuticals的總裁兼COO Tina Marriott以6.69美元/股的價格完成了14,319股A類普通股的出售，總交易額爲95,794.11美元。交易後，Marriott在Recursion Pharmaceuticals的直接持股總數爲521,138股。該交易是在一項指示通過交付或扣除證券支付行權價格或稅務負債的交易代碼下進行的。
2024年8月15日，Recursion Pharmaceuticals的總裁兼COO Tina Marriott以6.69美元/股的價格完成了14,319股A類普通股的出售，總交易額爲95,794.11美元。交易後，Marriott在Recursion Pharmaceuticals的直接持股總數爲521,138股。該交易是在一項指示通過交付或扣除證券支付行權價格或稅務負債的交易代碼下進行的。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間